Moi University Open Access Repository

Barriers and facilitators to chemotherapy Initiation and adherence for patients with HIV-associated Kaposi’s Sarcoma in Kenya: A Qualitative study

Show simple item record

dc.contributor.author McMahon, Devon E
dc.contributor.author Singh, Rhea
dc.contributor.author Chemtai, Linda
dc.contributor.author Semeere, Aggrey
dc.contributor.author Byakwaga, Helen
dc.contributor.author Grant, Merridy
dc.contributor.author Laker-Oketta, Miriam
dc.contributor.author Lagat, Celestine
dc.contributor.author Collier, Sigrid
dc.contributor.author Maurer, Toby
dc.contributor.author Martin, Jeffrey
dc.contributor.author Bassett, Ingrid V
dc.contributor.author Butler, Lisa
dc.contributor.author Kiprono, Samson
dc.contributor.author Busakhala, Naftali
dc.contributor.author Freeman, Esther E.
dc.date.accessioned 2022-06-20T07:48:23Z
dc.date.available 2022-06-20T07:48:23Z
dc.date.issued 2022-04-06
dc.identifier.uri https://doi.org/10.21203/rs.3.rs-1519625/v1
dc.identifier.uri http://ir.mu.ac.ke:8080/jspui/handle/123456789/6447
dc.description.abstract Background: Kaposi sarcoma is one of the most prevalent HIV-associated malignancies in sub-Saharan Africa and is often diagnosed at advanced stage of disease. Only 50% of KS patients who qualify for chemotherapy receive it and adherence is sub-optimal. Methods: 57 patients >18 years with newly diagnosed KS within the AMPATH clinic network in Western Kenya were purposively selected to participate in semi-structured interviews stratified by whether they had completed or not completed chemotherapy for advanced stage KS. We based the interview guide and coding framework on the situated Information, Motivation, Behavioral Skills (sIMB), in which the core patient centered IMB constructs are situated into the socioecological context of receiving care. Results: Of the 57 participants, the median age was 37 (IQR 32-41) and the majority were male (68%). Notable barriers to chemotherapy initiation and adherence included lack of financial means, difficulty with convenience of appointments such as distance to facility, appointment times, long lines, limited appointments, intrapersonal barriers such as fear or hopelessness, and lack of proper or sufficient information about chemotherapy. Factors that facilitated chemotherapy initiation and adherence included health literacy, motivation to treat symptoms, improvement on chemotherapy, prioritization of self-care, resilience while experiencing side effects, ability to carry out behavioral skills, obtaining national health insurance, and free chemotherapy. Conclusion: Our findings about the barriers and facilitators to chemotherapy initiation and adherence for KS in Western Kenya support further work that promotes public health campaigns with reliable cancer and chemotherapy information, improves education about the chemotherapy process and side effects, increases oncology service ability, supports enrollment in national health insurance, and increases incorporation of chronic disease care into existing HIV treatment networks. en_US
dc.description.sponsorship U01AI069911 en_US
dc.language.iso en en_US
dc.publisher Research square en_US
dc.subject Kaposi Sarcoma en_US
dc.subject Hiv/Aids en_US
dc.subject Chemotherapy en_US
dc.subject Treatment, en_US
dc.title Barriers and facilitators to chemotherapy Initiation and adherence for patients with HIV-associated Kaposi’s Sarcoma in Kenya: A Qualitative study en_US
dc.type Article en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account